BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35728279)

  • 1. 2D-DIGE based urinary proteomics and functional enrichment studies to reveal novel Mycobacterium tuberculosis and human protein biomarker candidates for pulmonary tuberculosis.
    Kaushik A; Bandyopadhyay S; Porwal C; Srinivasan A; Rukmangadachar LA; Hariprasad G; Kola S; Kataria J; Singh UB
    Biochem Biophys Res Commun; 2022 Sep; 619():15-21. PubMed ID: 35728279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS.
    Xu DD; Deng DF; Li X; Wei LL; Li YY; Yang XY; Yu W; Wang C; Jiang TT; Li ZJ; Chen ZL; Zhang X; Liu JY; Ping ZP; Qiu YQ; Li JC
    Proteomics; 2014 Feb; 14(2-3):322-31. PubMed ID: 24339194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum proteomics analysis for differentiation among Mycobacterium tuberculosis infection categories.
    Kaewseekhao B; Sirichoat A; Roytrakul S; Yingchutrakul Y; Reechaipichitkul W; Faksri K
    Tuberculosis (Edinb); 2023 Jul; 141():102366. PubMed ID: 37379738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers.
    Schiff HF; Walker NF; Ugarte-Gil C; Tebruegge M; Manousopoulou A; Garbis SD; Mansour S; Wong PHM; Rockett G; Piazza P; Niranjan M; Vallejo AF; Woelk CH; Wilkinson RJ; Tezera LB; Garay-Baquero D; Elkington P
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38512356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of tuberculosis biomarkers in human urine samples.
    Young BL; Mlamla Z; Gqamana PP; Smit S; Roberts T; Peter J; Theron G; Govender U; Dheda K; Blackburn J
    Eur Respir J; 2014 Jun; 43(6):1719-29. PubMed ID: 24743962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS.
    Xu D; Li Y; Li X; Wei LL; Pan Z; Jiang TT; Chen ZL; Wang C; Cao WM; Zhang X; Ping ZP; Liu CM; Liu JY; Li ZJ; Li JC
    Proteomics; 2015 Jan; 15(1):58-67. PubMed ID: 25332062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Mycobacterium tuberculosis proteome by liquid chromatography mass spectrometry-based proteomics techniques: a comprehensive resource for tuberculosis research.
    Bell C; Smith GT; Sweredoski MJ; Hess S
    J Proteome Res; 2012 Jan; 11(1):119-30. PubMed ID: 22053987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profile of Mycobacterium tuberculosis after eupomatenoid-5 induction reveals potential drug targets.
    Ghiraldi-Lopes LD; Campanerut-Sá PA; Meneguello JE; Seixas FA; Lopes-Ortiz MA; Scodro RB; Pires CT; da Silva RZ; Siqueira VL; Nakamura CV; Cardoso RF
    Future Microbiol; 2017 Aug; 12():867-879. PubMed ID: 28686056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
    Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV
    Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis.
    Liu J; Li Y; Wei L; Yang X; Xie Z; Jiang T; Wang C; Zhang X; Xu D; Chen Z; Yang F; Li JC
    J Ethnopharmacol; 2014 Sep; 155(2):1322-31. PubMed ID: 25072359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin-antitoxin systems.
    Albrethsen J; Agner J; Piersma SR; Højrup P; Pham TV; Weldingh K; Jimenez CR; Andersen P; Rosenkrands I
    Mol Cell Proteomics; 2013 May; 12(5):1180-91. PubMed ID: 23345537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of tuberculosis-associated proteins in whole blood supernatant.
    Tanaka T; Sakurada S; Kano K; Takahashi E; Yasuda K; Hirano H; Kaburagi Y; Kobayashi N; Hang NT; Lien LT; Matsushita I; Hijikata M; Uchida T; Keicho N
    BMC Infect Dis; 2011 Mar; 11():71. PubMed ID: 21418657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Group of Novel Serum Diagnostic Biomarkers for Multidrug-Resistant Tuberculosis by iTRAQ-2D LC-MS/MS and Solexa Sequencing.
    Wang C; Liu CM; Wei LL; Shi LY; Pan ZF; Mao LG; Wan XC; Ping ZP; Jiang TT; Chen ZL; Li ZJ; Li JC
    Int J Biol Sci; 2016; 12(2):246-56. PubMed ID: 26884721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis.
    Kedia K; Wendler JP; Baker ES; Burnum-Johnson KE; Jarsberg LG; Stratton KG; Wright AT; Piehowski PD; Gritsenko MA; Lewinsohn DM; Sigal GB; Weiner MH; Smith RD; Jacobs JM; Nahid P
    Tuberculosis (Edinb); 2018 Sep; 112():52-61. PubMed ID: 30205969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of drug-resistant Mycobacterium tuberculosis by one-dimensional gel electrophoresis and charge chromatography.
    Yari S; Hadizadeh Tasbiti A; Ghanei M; Shokrgozar MA; Fateh A; Mahdian R; Yari F; Bahrmand A
    Arch Microbiol; 2017 Jan; 199(1):9-15. PubMed ID: 27417316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential urine proteins and microRNA biomarkers for the diagnosis of pulmonary tuberculosis patients.
    Wang J; Zhu X; Xiong X; Ge P; Liu H; Ren N; Khan FA; Zhou X; Zhang L; Yuan X; Chen X; Chen Y; Hu C; Robertson ID; Chen H; Guo A
    Emerg Microbes Infect; 2018 Apr; 7(1):63. PubMed ID: 29636444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution quantitative proteomics applied to the study of the specific protein signature in the sputum and saliva of active tuberculosis patients and their infected and uninfected contacts.
    Mateos J; Estévez O; González-Fernández Á; Anibarro L; Pallarés Á; Reljic R; Gallardo JM; Medina I; Carrera M
    J Proteomics; 2019 Mar; 195():41-52. PubMed ID: 30660769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region.
    Jarsberg LG; Kedia K; Wendler J; Wright AT; Piehowski PD; Gritsenko MA; Shi T; Lewinsohn DM; Sigal GB; Weiner MH; Smith RD; Keane J; Jacobs JM; Nahid P
    PLoS One; 2021; 16(5):e0250586. PubMed ID: 33951066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.